Jump to content
  • Sign Up
       (0 reviews)

    OZ Stoners
    • Australian Natural Therapeutics Group

    Guided by a formidable board comprising adept commercial luminaries, this organisation boasts a multidisciplinary ensemble of talents — from renowned horticulturalists and avant-garde scientific researchers to astute medical advisors well-versed in the nuances of medicinal cannabis. Driven by an unwavering belief in the transformative health benefits of plant-based therapies, particularly cannabis-derived treatments, the team's dedication to enhancing patient wellbeing is palpable.

    The core of their ethos hinges on a profound respect for the intricate science of cannabis genetics. They firmly maintain that the journey towards top-tier medicinal cannabis products begins with the meticulous development of optimal genetics. Through diligent selective breeding practices, they've sculpted plant varieties teeming with medicinal potency, characterised by distinct terpene profiles and exceptional yield quality.

    Innovation isn't just a buzzword for them; it's the bedrock of their operations. The team channels countless hours into the pioneering development of strain-specific, plant-based medicines — each formula bearing the distinct hallmark of their expertise. Their stature as an Australian GMP-certified entity further accentuates their commitment to excellence. Every facet of their production and manufacturing protocols undergoes stringent independent verification, ensuring adherence to the most exacting pharmaceutical quality standards on a global scale.

    Their approach to quality assurance isn't just rigorous — it's exemplary. By ensuring that their industry-leading cannabis products undergo stringent controls and that standardization processes and testing methodologies are both consistent and replicable, they've set a benchmark in pharmaceutical quality within the Australian cannabis industry.

    ANTG's R&D endeavours encompass a dual-pronged focus: the meticulous development of avant-garde products and ground breaking clinical research. This dual focus ensures that they're always at the vanguard of cannabis medicine innovation. Emphasising the creation of multiple whole-plant formulations derived from identical strains, their R&D wing operates at the zenith of innovation, tailoring a diverse product suite to meet the unique therapeutic needs of patients.

    For them, the evolution of scientific understanding isn't just beneficial—it's pivotal. They perceive the relentless pursuit of knowledge as the primary catalyst propelling both the medicinal cannabis sector and the broader community into a brighter, healthier future. Their deep-seated commitment to clinical research isn't just a strategy; it's an ethos. Collaborating with esteemed university partners, their R&D division spearheads a myriad of research projects, spanning from intricate pre-clinical lab studies to expansive human clinical trials.

    User Feedback

    Join the conversation

    You can post now and register later. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.


  • Create New...

Important Information

By using the community in any way you agree to our Terms of Use and We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.